Shailja Kaul is an Endocrinology/Metabolic physician affiliated with Penn State Milton S. Hershey Medical Center. OpenAlex indexes 8 publications with 210 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
174 Middletown Blvd Ste 304
Langhorne, PA 19047
Telephone
215-757-2359Provider last certified this registry record 12 Sept 2023.
Industry payments
52 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20259 payments
- Novo Nordisk IncProgram year20255 payments
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
76.9%GLP-1 receptor agonist20.5%Ozempic49%Mounjaro30%Trulicity21%Part D≥106 patientsInsulin Analog17.2%Lantus Solostar24%Novolog Flexpen20%Tresiba Flextouch U-10016%Humalog Kwikpen U-1009%Toujeo Solostar7%Fiasp Flextouch6%Toujeo Max Solostar5%Novolog5%Basaglar Kwikpen U-1004%Insulin Aspart Flexpen3%Lyumjev Kwikpen U-1002%Part D<11 patients+ 8 more classes in this area
Hormonal (systemic)
18.3%l-Thyroxine15%Levothyroxine Sodium76%Synthroid15%Unithroid9%Part D≥154 patientsThyroid Hormone Synthesis Inhibitor3.3%Methimazole100%Part D≥33 patientsCardiovascular
2.2%Thiazide diuretic0.7%Hydrochlorothiazide100%Part D<11 patientsBeta blocker0.5%Atenolol100%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Podiatric Physicians' Perspectives on Their Role in Promoting Self-Care in High-Risk Patients with Diabetes
Journal of the American Podiatric Medical Association
2014 - Podiatrists' perspectives on their role in promoting self-care in high-risk patients with diabetes
Journal of the American Podiatric Medical Association
2014 - The Human Experience With Ghrelin Administration
The Journal of Clinical Endocrinology & Metabolism
2013
Similar KOLs
Other experts from the same institution or the same specialty.
Nancy Olsen, MD
Penn State Milton S. Hershey Medical Center
Michael Glantz, MD
Penn State Milton S. Hershey Medical Center
Joel Sorosky, MD
Penn State Milton S. Hershey Medical Center
Shin Mineishi, MD
Penn State Milton S. Hershey Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”